Clinical trial
A Study of DXC014 in Patients With Advanced Solid Tumors.
NCT07177937
Study timeline
Study start (actual)2026-03-03Date precision: day
Registry last updated2026-09-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Small Cell Lung Cancerunresolved
Melanomaunresolved
Prostate Cancerunresolved
Other Advanced Solid Tumorsunresolved
Interventions
DXC014DRUG
Sponsors & collaborators
Hangzhou DAC Biotechnology Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07177937 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.